Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 January 2019 | Story Zama Feni | Photo Barend Nagel
Prof Matlabisa
Prof Motlalepula Matlabisa of the Department of Pharmacology.

Two South African government departments have granted the University of the Free State’s Department of Pharmacology a combined amount of R15 million for the establishment of four tea farms in the disadvantaged communities in the North West and Eastern Cape Communities.

The head of the project Prof Motlalepula Matsabisa at the Department of Pharmacology said that that Department of Environmental Affairs (DEA) has granted an amount of R10 million for the community research in the respective provinces.

This grant is a top up to the R5 million they received from the Department of Science and Technology for the “community implementation on indigenous health infusions or teas as commonly known.”

The DEA will in the near future sign a Memorandum of Agreement (MOA) with the university.


Tea project set to empower communities


“The project is to implement and build structures in the four communities we work with in the North West and Eastern Cape,” he said.

The identified areas for the project are in the Eastern Cape towns of Alice and Idutywa as well another two North West communities in Zeerust.

Prof Matsabisa indicated that the project will be a manifestation of “how science can contribute to economic growth, poverty alleviation and job creation.” 

“It was very interesting to have discovered that some French and German companies have already displayed interest in the projects,” he said.

He stated that a project of this nature is a good initiative by the UFS and it will also show that the university’s research activities are national. “We have been researching and developing indigenous teas which have now attracted interest locally and internationally by huge companies such as Nestle, Tiger Brands, Moringa World etc,” he said. 


Taking it slowly


At the initial stages of the tea farming project, Prof Matsabisa said they would start in small portions of utilising five hectares in each of the four projects and as the project gains momentum, they would expand.

Prof Matlabisa said that an environmental impact assessment has already been conducted and they were waiting for the DEA to give them a go ahead for the land preparations.



News Archive

UFS Expert: Prof Felicity Burt investigates zoonotic and arboviruses
2017-12-13


 Description: Burt read more 2 Tags: Arboviruses, Felicity Burt, Crimean-Congo haemorrhagic fever, viruses  

Prof Felicity Burt recently received a B-rating from the
National Research
Foundation.
Photo: Sonia Small

Prof Felicity Burt is from the Division of Virology in the Faculty of Health Sciences at the University of the Free State (UFS), as well as the National Health Laboratory Services (NHLS). She currently holds an NRF-DST South African Research Chair in vector-borne and zoonotic diseases.  Professor Burt and her research group investigate arboviruses and zoonotic viruses. 

Prof Burt’s research primarily focuses on host immune responses to arboviral infections specifically characterising humoral and cellular immune responses in patients with infections such as Crimean-Congo haemorrhagic fever (CCHF) virus and Sindbis virus; epitope discovery for development of diagnostic tools; development of molecular and serological assays for surveillance purposes; virus discovery; and the development of vaccines.

Raising awareness of these viruses, defining associated diseases, and developing tools for surveillance programmes will contribute to understanding these pathogens as well as the public health implications.

Leads research group in papilloma viruses
Arboviruses cause outbreaks of disease in South Africa annually. Outbreaks are usually associated with heavy rainfall favouring the breeding of mosquitos, but these viruses also have the capacity to spread and become endemic in new areas where competent vectors are present. 
In addition, she is leading a research group that investigates human papilloma viruses (HPV) associated with head and neck cancers and recurrent laryngeal papilloma.

The focus of this research group is to ascertain the genotypes of HPV causing these diseases, identification of novel biomarkers for early detection, and complete genome sequencing for molecular characterisation of HPV isolates.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept